Clinical Trials Logo

Benign Disease clinical trials

View clinical trials related to Benign Disease.

Filter by:
  • None
  • Page 1

NCT ID: NCT02065453 Completed - Clinical trials for Laparoscopic Hysterectomy

Disposable Energy Sources and Operating Room Time for Laparoscopic Hysterectomy

Start date: January 2012
Phase: N/A
Study type: Interventional

Over 600,000 hysterectomies are performed each year nationwide. Over 99% of these are accomplished laparoscopically in the investigators current surgical practice to allow women a quicker recovery than a traditional large incision. Disposable laparoscopic devices have been developed to assist in the completion of hysterectomies. These disposable energy sources are only used once, but offer an improved safety and energy profile in that they reliably control bleeding with little damage to surrounding tissue and potentially save time. Reusable energy instruments can be sterilized and reused for multiple cases. Operating room time is expensive. The investigators calculate that if 6.7 minutes of time can be saved using the disposable device, Ligasure (Covidien), versus the reusable Robi bipolar and Storz Laparoscopic Shears, the time savings could justify the cost of the device.

NCT ID: NCT00894725 Completed - Colon Cancer Clinical Trials

Laparoscopic Versus Open Left Colonic Resection

Start date: February 2000
Phase: Phase 3
Study type: Interventional

The main goal of this study is to clarify if laparoscopy (LPS) could become the standard approach in patients undergoing left colonic resection. 268 patient candidates to left colonic resection were randomly assigned to LPS (n=134) or open (n=134) approach. Postoperative care protocol was the same in both groups. Trained members of the surgical staff who were not involved in the study registered 30-day postoperative morbidity. Cost-benefit analysis was based on hospital costs. Long-term morbidity, quality of life, and 5-year survival have also been evaluated.

NCT ID: NCT00751452 Recruiting - Benign Disease Clinical Trials

Citrulline Allo. Evaluation of Citrullinemia as a Marker of Bowel Damage After Allogeneic Bone Marrow Transplantation in Children

Start date: April 2008
Phase: N/A
Study type: Observational

determine the interest of the dosage of citrullinemia to monitor the bowel damage after allogeneic bone marrow transplantation in children.

NCT ID: NCT00574678 Completed - Breast Cancer Clinical Trials

Analyzing the Composition of Tears to Identify Cancer

ACT
Start date: December 2006
Phase: Phase 1/Phase 2
Study type: Interventional

This study will further evaluate the use of protein identification or protein pattern (signature) found in tears. We hypothesize that differences exist between the protein profile in tear fluid from patients with versus without cancer.